OpenVSafe by OpenVAERS
Search V-safe

63P-20254-96936

3 vaccinations 15 coded responses 33 check-ins 14 free-text entries 8 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
920 / CA
Registered
2021-05-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-05-20
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-21
    Registered in v-safe
  3. 2021-05-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness
    Adult check-in
  4. 2021-05-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  5. 2021-05-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-05-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Swelling · Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  7. 2021-05-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  8. 2021-05-27
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness, Abdominal pain
    Adult check-in
  9. 2021-06-03
    Survey response — day 14, dose 1
    MedDRA: Heavy menstrual bleeding — Feeling: Fair
    Free text: Really strange bleeding with period. In fact, I don't normally get periods at all, but I've had a very long and weird one.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-06-10
    Survey response — day 21, dose 1
    MedDRA: Asthma, Pre-existing disease — Feeling: Good · Be unable to work, Be unable to do your normal daily activities
    Free text: Worst asthma of my life.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-06-17
    Survey response — day 28, dose 1
    MedDRA: Abdominal pain — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Daily abdominal pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-06-24
    Survey response — day 35, dose 1
    MedDRA: Hypoglycaemia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Hypoglycemia verified by glucose monitor. Also, free light chain ratio is off with too many free kappa chains.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-06-24
    Report sent to call center — day 35, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-06-30
  15. 2021-07-01
    Health check-in — day 42, dose 1
    Feeling: Good
    Adult check-in
  16. 2021-07-01
  17. 2021-08-19
    Survey response — 3 months, dose 1
    MedDRA: Nervous system disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: I am having brachial plexus issues in my entire arm.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  18. 2021-08-19
    Report sent to call center — 3 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  19. 2021-08-26
    Call successful
    Participant prefers to complete VAERS report online
  20. 2021-08-26
    Call successful
    Participant prefers to complete VAERS report online
  21. 2021-09-16
    Dose 2 — Pfizer-BioNTech
  22. 2021-09-27
    Health check-in — day 7, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  23. 2021-09-30
    Survey response — day 14, dose 2
    MedDRA: Arthralgia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Joint pain
    MedDRA releases: 2024-11 · check-in free text available
  24. 2021-10-07
    Survey response — day 21, dose 2
    MedDRA: Vaginal haemorrhage — Feeling: Fair
    Free text: unusual vaginal bleeding
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-10-15
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  26. 2021-10-21
    Survey response — day 35, dose 2
    MedDRA: Antiphospholipid antibodies positive, Red blood cell sedimentation rate increased — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Suddenly I have antiphospholipid antibodies and a high sedimentation rate.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-10-21
    Report sent to call center — day 35, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  28. 2021-10-27
    Call successful
    Participant prefers to complete VAERS report online
  29. 2021-10-28
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  30. 2021-12-16
    Survey response — 3 months, dose 2
    MedDRA: Blood homocysteine increased, Factor VIII activity increased, Hypergammaglobulinaemia benign monoclonal — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: MGUS, high homocysteine, high Factor viii activity.
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-12-16
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  32. 2021-12-18
  33. 2022-03-17
    Survey response — 6 months, dose 2
    MedDRA: Undifferentiated connective tissue disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Undifferentiated connective tissue disease
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-03-17
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  35. 2022-03-23
  36. 2022-04-25
    Dose 3 — Pfizer-BioNTech
  37. 2022-04-26
    Survey response — days 1–6 daily, dose 3
    MedDRA: Axillary pain, Oedema peripheral, Paraesthesia — Feeling: Fair · Site: Pain, Swelling, Itching · Joint pains · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Pain and swelling in armpit and tingling down arm to fingers.
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-04-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: Burning sensation — Feeling: Poor · Site: Pain, Redness, Swelling · Muscle or body aches · Be unable to work or attend school
    Free text: Burning pain on that arm
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-04-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Swelling · Joint pains, Nausea
    Adult check-in
  40. 2022-04-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Swelling · Headache, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  41. 2022-05-02
    Health check-in — day 7, dose 3
    Feeling: Fair · None
    Adult check-in
  42. 2022-05-09
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  43. 2022-05-16
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  44. 2022-05-24
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  45. 2022-05-30
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  46. 2022-06-06
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  47. 2022-07-26
    Survey response — 3 months, dose 3
    MedDRA: Arthralgia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Joint pain and soreness
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-07-26
    Report sent to call center — 3 months, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  49. 2022-07-26
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  50. 2022-07-26
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  51. 2022-07-26
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  52. 2022-10-24
    Survey response — 6 months, dose 3
    MedDRA: Autoimmune disorder, Hypergammaglobulinaemia benign monoclonal — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: I now have an autoimmune disease and MGUS.
    MedDRA releases: 2024-11 · check-in free text available
  53. 2022-10-24
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  54. 2022-10-25
  55. 2023-04-30
    Survey response — 12 months, dose 3
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  56. 2023-04-30
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  57. 2023-05-01
  58. 2023-05-01

Vaccinations

DoseDateManufacturerCo-administered
12021-05-20Pfizer-BioNTech
22021-09-16Pfizer-BioNTech No
32022-04-25Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-06-24 Successful
2021-08-26
Participant prefers to complete VAERS report online
2021-08-19 Successful
2021-08-26
Participant prefers to complete VAERS report online
2021-10-21 Successful
2021-10-27
Participant prefers to complete VAERS report online
2021-12-16 Successful
2022-07-26
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-03-17 Successful
2022-07-26
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-07-26 Successful
2022-07-26
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-10-24 Unsuccessful
2023-04-30 Unsuccessful

Free text

Release 8 — day 14, dose 1

2021-06-03

Symptoms: Really strange bleeding with period. In fact, I don't normally get periods at all, but I've had a very long and weird one.

Release 9 — day 21, dose 1

2021-06-10

Symptoms: Worst asthma of my life.

Release 9 — day 28, dose 1

2021-06-17

Symptoms: Daily abdominal pain

Release 9 — day 35, dose 1

2021-06-24

Symptoms: Hypoglycemia verified by glucose monitor. Also, free light chain ratio is off with too many free kappa chains.

Release 9 — 3 months, dose 1

2021-08-19

Symptoms: I am having brachial plexus issues in my entire arm.

Release 9 — day 14, dose 2

2021-09-30

Symptoms: Joint pain

Release 10 — day 21, dose 2

2021-10-07

Symptoms: unusual vaginal bleeding

Release 10 — day 35, dose 2

2021-10-21

Symptoms: Suddenly I have antiphospholipid antibodies and a high sedimentation rate.

Release 10 — 3 months, dose 2

2021-12-16

Symptoms: MGUS, high homocysteine, high Factor viii activity.

Release 11 — 6 months, dose 2

2022-03-17

Symptoms: Undifferentiated connective tissue disease

Release 11 — days 1–6 daily, dose 3

2022-04-26

Systemic reaction (other): Pain and swelling in armpit and tingling down arm to fingers.

2022-04-27

Systemic reaction (other): Burning pain on that arm

Release 12 — 3 months, dose 3

2022-07-26

Symptoms: Joint pain and soreness

Release 12 — 6 months, dose 3

2022-10-24

Symptoms: I now have an autoimmune disease and MGUS.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain ✓ ✓ ✓
SDAntiphospholipid antibodies positive · · ✓
SDArthralgia · · ✓
SDAsthma ✓ ✓ ✓
SDAutoimmune disorder · · ✓
SDBlood homocysteine increased · · ✓
SDCOVID-19 · · ✓
SDFactor VIII activity increased · · ✓
SDHeavy menstrual bleeding ✓ ✓ ✓
SDHypergammaglobulinaemia benign monoclonal · · ✓
SDHypoglycaemia ✓ ✓ ✓
SDNervous system disorder ✓ · ✓
SDPre-existing disease ✓ ✓ ✓
SDRed blood cell sedimentation rate increased · · ✓
SDUndifferentiated connective tissue disease · · ✓
SDVaginal haemorrhage · · ✓
SROAxillary pain · · ✓
SROBurning sensation · · ✓
SROOedema peripheral · · ✓
SROParaesthesia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release